Almirall, S.A. (FRA:E2Z)

Germany flag Germany · Delayed Price · Currency is EUR
10.96
+0.16 (1.48%)
Last updated: Jul 30, 2025
1.48%
Market Cap2.27B
Revenue (ttm)1.05B
Net Income (ttm)21.34M
Shares Outn/a
EPS (ttm)0.10
PE Ratio106.51
Forward PE30.59
Dividend0.15 (1.39%)
Ex-Dividend DateMay 15, 2025
Volumen/a
Average Volume150
Open10.96
Previous Close10.80
Day's Range10.96 - 10.96
52-Week Range8.09 - 11.28
Betan/a
RSI42.83
Earnings DateJul 25, 2025

About Accolade

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun... [Read more]

Industry Pharmaceutical Preparations
Founded 1943
Employees 2,026
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol E2Z
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.